Additional file 1: Table S1. of Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation

Mazzola, Maria; Raheja, Radhika; Murugaiyan, Gopal; Rajabi, Hasan; Kumar, Deepak; Pertel, Thomas; Regev, Keren; Griffin, Russell; Aly, Lilian; Kivisakk, Pia; Nejad, Parham; Patel, Bonny; Gwanyalla, Nguendab; Hei, Hillary; Glanz, Bonnie; Chitnis, Tanuja; Weiner, Howard; Gandhi, Roopali

doi:10.6084/m9.figshare.c.3602255_D1.v1

12974_2015_460_MOESM1_ESM.pdf (512.43 kB)

Additional file 1: Table S1. of Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation

journal contribution

posted on 2015-12-30, 05:00 authored by Maria Mazzola, Radhika Raheja, Gopal Murugaiyan, Hasan Rajabi, Deepak Kumar, Thomas Pertel, Keren Regev, Russell Griffin, Lilian Aly, Pia Kivisakk, Parham Nejad, Bonny Patel, Nguendab Gwanyalla, Hillary Hei, Bonnie Glanz, Tanuja Chitnis, Howard Weiner, Roopali Gandhi

Multiple sclerosis patient characteristics. All multiple sclerosis patients had relapsing-remitting disease courses. s.d.â=âstandard deviation.

Funding

Novartis Pharmaceuticals Corporation

History

Usage metrics

Keywords

Multiple sclerosis Fingolimod (FTY720)TCF-1 IFN-Îł Granzyme B

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: Table S1. of Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation

Funding

Novartis Pharmaceuticals Corporation

History

Usage metrics

Categories

Keywords

Licence

Exports